These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 31746129)

  • 1. Treatment of glycemic control in diabetes in the CVOT era.
    Einhorn D
    J Diabetes; 2020 Jan; 12(1):4. PubMed ID: 31746129
    [No Abstract]   [Full Text] [Related]  

  • 2. Back to glycemic control: An alternative look at the results of cardiovascular outcome trials in type 2 diabetes.
    Mannucci E; Monami M; Ceriello A; Rotella CM
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):375-377. PubMed ID: 28242233
    [No Abstract]   [Full Text] [Related]  

  • 3. [HbA1c 8.5% in elderly people with diabetes: is it good enough?].
    Bottermann P
    MMW Fortschr Med; 2009 Jun; 151(26-29):38-9. PubMed ID: 19739547
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes. Paradoxical effects of tightly controlled blood sugar.
    Taubes G
    Science; 2008 Oct; 322(5900):365-7. PubMed ID: 18927369
    [No Abstract]   [Full Text] [Related]  

  • 5. Is glycemic control a quinidine-like intervention?
    Bloomgarden ZT
    J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical research. Deaths in diabetes trial challenge a long-held theory.
    Couzin J
    Science; 2008 Feb; 319(5865):884-5. PubMed ID: 18276854
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intensive glucose control in type 2 diabetes is beneficial].
    Nilsson PM; Attvall S
    Lakartidningen; 2009 Sep 2-8; 106(36):2198. PubMed ID: 19817174
    [No Abstract]   [Full Text] [Related]  

  • 8. Obesity and Type 2 diabetes mellitus.
    Wilding J
    Diabet Med; 2000 May; 17(5):400-2. PubMed ID: 10872543
    [No Abstract]   [Full Text] [Related]  

  • 9. Decrease mortality in type II diabetes mellitus: glycemic and renal function control.
    Borghi C; Ventura F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e13-e15. PubMed ID: 29538138
    [No Abstract]   [Full Text] [Related]  

  • 10. Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force.
    Jellinger PS; Davidson JA; Blonde L; Einhorn D; Grunberger G; Handelsman Y; Hellman R; Lebovitz H; Levy P; Roberts VL;
    Endocr Pract; 2007; 13(3):260-8. PubMed ID: 17599857
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current methods of glucose metabolism control in diabetes mellitus].
    Scarpitta AM; Sinagra D
    Recenti Prog Med; 2003 Jan; 94(1):31-40. PubMed ID: 12632998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An overweight diabetic does not tolerate metformin. Insulin sensitizer can be prescribed alone, too].
    MMW Fortschr Med; 2003 Dec; 145(49):58. PubMed ID: 14963999
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus.
    Werzowa J; Pacini G; Hecking M; Fidler C; Haidinger M; Brath H; Thomas A; Säemann MD; Tura A
    J Diabetes Complications; 2015; 29(8):1211-6. PubMed ID: 26264400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of community-managed blood glucose control in patients with diabetes mellitus in Shenzhen, China.
    Fang L; Li Q; Ning J
    J Diabetes; 2024 Jul; 16(7):e13573. PubMed ID: 38923123
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes managment: Beyond hemoglobin A
    Makin V; Lansang MC
    Cleve Clin J Med; 2019 Sep; 86(9):595-600. PubMed ID: 31498766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute blood sugar peaks endanger blood vessels: the postprandial situation to be controlled better].
    MMW Fortschr Med; 2006 Jun; 148(26):57. PubMed ID: 16875385
    [No Abstract]   [Full Text] [Related]  

  • 17. Agents for the treatment of diabetes mellitus.
    O'Mara NB
    Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919
    [No Abstract]   [Full Text] [Related]  

  • 18. Intensive glycemic control: implications of the accord, advance, and VADT trials for family physicians.
    Dhar GC
    Can Fam Physician; 2009 Aug; 55(8):803-4. PubMed ID: 19675265
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycemic durability of monotherapy for diabetes.
    Parashar A; Varma A
    N Engl J Med; 2007 Mar; 356(13):1379; author reply 1380. PubMed ID: 17402164
    [No Abstract]   [Full Text] [Related]  

  • 20. Point: Intensive glycemic control and mortality in ACCORD--a chance finding?
    Lachin JM
    Diabetes Care; 2010 Dec; 33(12):2719-21. PubMed ID: 21115777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.